Product Information
EZETIMIBE-SIMVASTATIN 10-40 MG is a generic product, priced at $0.2368 per EA under NDC 43598058510. Its NADAC has been published 475 times since Jul 19, 2017.
Heads up: FDA NDC-directory enrichment for this product is incomplete — manufacturer is not populated for this NDC in the latest weekly file. The NADAC price and history below are still authoritative; the surrounding metadata is limited to what the CMS publication itself carries.
EZETIMIBE-SIMVASTATIN 10-40 MG
NDC
43598058510
Classification
Generic
Effective Date
8/19/2026
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-40 MG has been published 475 times since Jul 19, 2017, and over the history we have for it it has declined 91.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2368 per EA |
|---|---|
| All-time high | $3.0030 (Sep 13, 2017) |
| All-time low | $0.2368 (Aug 19, 2026) |
| 52-week high | $0.5024 |
| 52-week low | $0.2368 |
| Median price | $0.8875 |
| Average price | $1.1757 |
| Largest weekly change | +78.2% (May 18, 2022) |
| Weeks tracked | 475 |
| Tracking since | Jul 19, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the drug market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-40 MG is $0.2368 per EA (NDC 43598058510), effective Aug 19, 2026.
How has the price of EZETIMIBE-SIMVASTATIN 10-40 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-40 MG has declined 91.4%. It has been tracked across 475 weekly CMS publications since Jul 19, 2017.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-40 MG?
Since Jul 19, 2017, the NADAC for EZETIMIBE-SIMVASTATIN 10-40 MG has ranged from a low of $0.2368 (Aug 19, 2026) to a high of $3.0030 (Sep 13, 2017), with a median of $0.8875 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-40 MG?
No other NADAC-published product currently shares the active ingredient and strength of EZETIMIBE-SIMVASTATIN 10-40 MG in a comparable dosage form, so no direct lower-cost alternative is listed.